Tor‐Arne Hagve

4.1k total citations · 1 hit paper
115 papers, 3.1k citations indexed

About

Tor‐Arne Hagve is a scholar working on Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, Tor‐Arne Hagve has authored 115 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 32 papers in Nutrition and Dietetics and 31 papers in Molecular Biology. Recurrent topics in Tor‐Arne Hagve's work include Fatty Acid Research and Health (28 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Peroxisome Proliferator-Activated Receptors (15 papers). Tor‐Arne Hagve is often cited by papers focused on Fatty Acid Research and Health (28 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Peroxisome Proliferator-Activated Receptors (15 papers). Tor‐Arne Hagve collaborates with scholars based in Norway, United States and Finland. Tor‐Arne Hagve's co-authors include Bjørn O. Christophersen, Torbjørn Omland, Erik Christensen, Morten Grønn, Helge Røsjø, Arne Høiseth, Vidar Søyseth, Siri Lagethon Heck, Jürgen Geisler and Kjetil Steine and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and CHEST Journal.

In The Last Decade

Tor‐Arne Hagve

111 papers receiving 3.0k citations

Hit Papers

Prevention of cardiac dysfunction during adjuvant breast ... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    2016 440 citations Tor‐Arne Hagve, Helge Røsjø et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tor‐Arne Hagve Norway 34 1.0k 747 642 467 453 115 3.1k
Howard R. Knapp United States 30 566 0.6× 1.0k 1.4× 761 1.2× 333 0.7× 828 1.8× 56 3.9k
Reinhard Lorenz Germany 38 910 0.9× 778 1.0× 568 0.9× 779 1.7× 300 0.7× 102 5.1k
Andreas Pasch Switzerland 38 377 0.4× 993 1.3× 847 1.3× 818 1.8× 311 0.7× 134 4.5k
Michael Torzewski Germany 34 939 0.9× 359 0.5× 1.1k 1.7× 475 1.0× 604 1.3× 63 4.7k
J H Eckfeldt United States 25 704 0.7× 597 0.8× 535 0.8× 225 0.5× 389 0.9× 59 2.6k
Marc W. Merx Germany 32 1.3k 1.3× 309 0.4× 1.0k 1.6× 420 0.9× 902 2.0× 75 4.3k
Yasumasa Ikeda Japan 34 584 0.6× 333 0.4× 970 1.5× 467 1.0× 448 1.0× 151 3.5k
Juerg Nussberger Switzerland 28 2.4k 2.4× 383 0.5× 755 1.2× 236 0.5× 234 0.5× 72 4.2k
Seong Kwon South Korea 32 592 0.6× 218 0.3× 774 1.2× 572 1.2× 292 0.6× 243 3.4k
Marie J. Stuart United States 35 456 0.4× 319 0.4× 685 1.1× 446 1.0× 861 1.9× 127 4.7k

Countries citing papers authored by Tor‐Arne Hagve

Since Specialization
Citations

This map shows the geographic impact of Tor‐Arne Hagve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor‐Arne Hagve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor‐Arne Hagve more than expected).

Fields of papers citing papers by Tor‐Arne Hagve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor‐Arne Hagve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor‐Arne Hagve. The network helps show where Tor‐Arne Hagve may publish in the future.

Co-authorship network of co-authors of Tor‐Arne Hagve

This figure shows the co-authorship network connecting the top 25 collaborators of Tor‐Arne Hagve. A scholar is included among the top collaborators of Tor‐Arne Hagve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor‐Arne Hagve. Tor‐Arne Hagve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Einvik, Gunnar, et al.. (2022). It is unlikely that oxygen supplementation in COPD patients with chronic respiratory failure reduce cardiac troponin level. BMC Pulmonary Medicine. 22(1). 392–392. 2 indexed citations
2.
Holm, Sverre, Tor‐Arne Hagve, Kjell Saatvedt, et al.. (2019). Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study. BMJ Open. 9(5). e030651–e030651. 7 indexed citations
3.
4.
5.
Petäjä, Liisa, Helge Røsjø, Leena Mildh, et al.. (2016). Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interactive Cardiovascular and Thoracic Surgery. 23(1). 133–141. 25 indexed citations
6.
Myhre, Peder L., Marjaana Tiainen, Ville Pettilä, et al.. (2016). NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study. Resuscitation. 104. 12–18. 10 indexed citations
7.
Høiseth, Arne, Anke Neukamm, Tor‐Arne Hagve, et al.. (2014). The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations ofchronic obstructive pulmonary disease. Open Heart. 1(1). e000001–e000001. 12 indexed citations
8.
Aakre, Kristin M., Svein Rotevatn, Tor‐Arne Hagve, et al.. (2013). Nasjonale anbefalinger for tolkning av troponinverdier ved diagnostikk av akutt hjerteinfarkt. Tidsskrift for Den norske legeforening. 133(21). E1–6. 3 indexed citations
9.
Løken, Elin Bjørge, et al.. (2010). Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes?. Clinical Nutrition. 29(4). 525–530. 5 indexed citations
10.
Borch‐Iohnsen, Berit, Tor‐Arne Hagve, Anton Hauge, & Ketil Thorstensen. (2009). Regulering av jernbalansen. Tidsskrift for Den norske legeforening. 129(9). 858–862. 6 indexed citations
11.
Hagve, Tor‐Arne, et al.. (2005). Hemoglobinopatier og fremmedartede navn. Tidsskrift for Den Norske Laegeforening.
12.
Hagve, Tor‐Arne, et al.. (2005). Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scandinavian Journal of Gastroenterology. 41(4). 465–471. 13 indexed citations
13.
Hagve, Tor‐Arne. (2001). Desaturation and esterification of fatty acids in kidney cells from spontaneously hypertensive rats. Scandinavian Journal of Clinical and Laboratory Investigation. 61(2). 151–159. 5 indexed citations
14.
Hagve, Tor‐Arne, et al.. (1998). Membrane fluidity and fatty acid metabolism in kidney cells from rats fed purified eicosapentaenoic acid or purified docosahexaenoic acid. Scandinavian Journal of Clinical and Laboratory Investigation. 58(3). 187–194. 20 indexed citations
15.
Müller, Fredrik, et al.. (1997). Modification of mononuclear cell function after incubation with albumin‐bound unsaturated fatty acids or soybean oil emulsion. Apmis. 105(7-12). 671–679. 4 indexed citations
16.
Tonstad, Serena, Leiv Ose, Tor‐Arne Hagve, et al.. (1996). The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein(a) levels in familial hypercholesterolemia. Metabolism. 45(11). 1415–1421. 6 indexed citations
17.
Christensen, Erik, Tor‐Arne Hagve, Bwee Tien Poll‐The, et al.. (1993). Peroxisomal β-oxidation of Polyunsaturated Long Chain Fatty Acids in Human Fibroblasts. The Polyunsaturated and the Saturated Long Chain Fatty Acids are Retroconverted by the Same Acyl-CoA Oxidase. Scandinavian Journal of Clinical and Laboratory Investigation. 53(sup215). 61–74. 49 indexed citations
18.
Hagve, Tor‐Arne, et al.. (1993). [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].. PubMed. 113(7). 853–6. 2 indexed citations
19.
Grønn, Morten, et al.. (1991). Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: A controlled dietetic study. Scandinavian Journal of Clinical and Laboratory Investigation. 51(3). 255–263. 41 indexed citations
20.
Hagve, Tor‐Arne, Michel Narce, Morten Grønn, et al.. (1989). The effect of dietary α-bromopalmitate on blood lipids in the rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1004(1). 143–146. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard R. Knapp Breakdown of academic impact, for papers by Reinhard Lorenz Breakdown of academic impact, for papers by Andreas Pasch Breakdown of academic impact, for papers by Michael Torzewski Breakdown of academic impact, for papers by J H Eckfeldt Breakdown of academic impact, for papers by Marc W. Merx Breakdown of academic impact, for papers by Yasumasa Ikeda Breakdown of academic impact, for papers by Juerg Nussberger Breakdown of academic impact, for papers by Seong Kwon Breakdown of academic impact, for papers by Marie J. Stuart
Rankless by CCL
2026